0001209191-23-045267.txt : 20230810
0001209191-23-045267.hdr.sgml : 20230810
20230810084711
ACCESSION NUMBER: 0001209191-23-045267
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230808
FILED AS OF DATE: 20230810
DATE AS OF CHANGE: 20230810
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Taylor Daphne
CENTRAL INDEX KEY: 0001393549
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37746
FILM NUMBER: 231157382
MAIL ADDRESS:
STREET 1: 3303 MONTE VILLA PARKWAY
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER NAME:
FORMER CONFORMED NAME: Taylor Daphne L
DATE OF NAME CHANGE: 20070316
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aptevo Therapeutics Inc.
CENTRAL INDEX KEY: 0001671584
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811567056
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
BUSINESS PHONE: 206-838-0500
MAIL ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-08-08
0
0001671584
Aptevo Therapeutics Inc.
APVO
0001393549
Taylor Daphne
C/O APTEVO THERAPEUTICS INC.
2401 4TH AVENUE, SUITE 1050
SEATTLE
WA
98121
0
1
0
0
SVP, CFO
0
Common Stock
2023-08-08
4
M
0
6945
A
12368
D
Restricted Stock Unit
2023-08-08
4
M
0
6945
0.00
D
Common Stock
6945
6944
D
Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
On August 9, 2022, the reporting person was granted 13,889 RSUs, vesting in two approximately equal installments beginning on August 8, 2023.
/s/ SoYoung Kwon, Attorney-in-Fact
2023-08-10